For some people, symptoms improve within a few weeks as the body acclimates
Our goal is not to sell more medications
Sodium-Glucose Co-Transporter-2 Inhibitors: Peculiar "Hybrid" Diuretics That Protect From Target Organ Damage and Cardiovascular Events
North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026
1 The GLP-1 hormone controls key metabolic processes: it triggers the release of insulin to reduce blood sugar levels after spikes, helps slow down digestion for optimal nutrient absorption and signals the brain when to stop eating
A beneficiary with a BMI of 32 and uncontrolled hypertension, or a BMI of 28 with pre-diabetes and a prior stroke, previously had no straightforward path to GLP-1 coverage